About: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1989 (uk) im November 1989 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1989 (en) artículu científicu espublizáu en payares de 1989 (ast)
publication date	wds:Q69360472-EFA421C7-84B1-40C6-ADC8-71339F0DAE88
publication date	1989-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q69360472-11E55EB7-86F3-4808-85D5-055F3B0FAE2F wds:Q69360472-1F14D0B5-245D-40C1-B644-5F73B60E5120 wds:Q69360472-2AF378E5-A211-4C3A-941A-67D657901F35 wds:Q69360472-444F0E2D-495D-4C0C-8E80-151FB29C9085 wds:Q69360472-4D853260-4D2D-40B9-8CC0-472964FFAEAC wds:Q69360472-4F001A9E-5DC6-4255-B3CF-1129323A0521 wds:Q69360472-65DD4B4D-842D-4430-819A-4107D0B574E3 wds:Q69360472-A299B084-8DAD-4A8B-9B28-A1D9FEC83E7F wds:Q69360472-BFF5695B-3E39-4E74-B4CD-7839F8798BA8 wds:Q69360472-EC11B8C5-3DEF-4459-AE05-91BC6A7F870E
author name string	R Willemze A Brand J W Gratama A M van Loon T H The L F Verdonck F W Sebens G C Mudde J G Houbiers Y C de Graan-Hentzen
rdfs:label	Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (en) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (nl)
skos:prefLabel	Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (en) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (nl)
name	Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (en) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (nl)
title	wds:Q69360472-5F8E8D58-3708-4836-B64C-2969615AE1AB
title	Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (en)
page(s)	wds:Q69360472-DEE8DC7C-13E0-4466-9D73-617B6CB71672
page(s)	757-760
instance of	wds:Q69360472-95A29F0C-4388-4BE8-99B0-35CFCB94EAE2
instance of	scholarly article
main subject	wds:Q69360472-420E1709-2828-4F28-A92E-66E947CCB857
main subject	cytomegaloviral disease
PubMed ID	wds:Q69360472-E43833C5-9CF6-425C-B4BC-AF2312F9C733
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2555938
PubMed ID	2555938
published in	wds:Q69360472-54C7584E-1593-4735-8433-DC1EF2F2447F
published in	Transfusion
issue	wds:Q69360472-F88816DE-A724-450B-A1E6-AA081144DDB3
volume	wds:Q69360472-ED1D1BF6-FCE2-4B9B-8313-22D9EF2064AE
issue	9
volume	29
DOI	wds:Q69360472-7096E021-8E23-4656-A7BF-1D92325629F9
DOI	http://dx.doi.org/10.1046/J.1537-2995.1989.29990070177.X
DOI	10.1046/J.1537-2995.1989.29990070177.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69360472
is cites work of	Diverse immune evasion strategies by human cytomegalovirus Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers The mechanisms of leukocyte removal by filtration Adverse haematological complications of anticancer drugs. Clinical presentation, management and avoidance Transfusion and stem cell support in cancer treatment Inactivation of cytomegalovirus in platelet concentrates using Helinx technology Leukocyte-Poor Blood Components: Issues and Indications Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection The use of leukocyte-reduced blood components. A lack of serologic evidence of transmission of Chlamydia pneumoniae by transfusion of buffy coat‐depleted RBCs Transfusion-transmitted cytomegalovirus infection Asymmetric membrane filters for the removal of leukocytes from blood Prestorage leukocyte depletion of blood products in a closed system. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? Update on leucocyte depletion of blood components by filtration The role of leukodepletion in the control of transfusion-transmitted disease The role of maternal screening in diagnosing congenital cytomegalovirus infections in highly immune populations Collection of WBC-reduced single-donor PLT concentrates with a new blood cell separator: results of a multicenter study Leukocyte filtration of single-donor platelet units through an integrated filter system for the Fresenius AS 104 blood cell separator [Multicenter study on the efficacy of leukocyte depletion by filtration of red cells. The Labile Blood Products Group] The role of blood microfilters in clinical practice Transfusion of the HIV-seropositive patient: immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8 Inactivation Of Microbial Contaminants Of Blood Components Transfusion-transmitted diseases other than AIDS and hepatitis Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients Leukocyte-poor blood components: a purer and safer transfusion product for recipients? Leukocyte depletion: a biotechnical transfusion story [Post-transfusional cytomegalovirus infections: incidence and methods of prevention. CMV group of SNTS] Manual and automated methods for the determination of leukocyte counts at extreme low levels: comparative evaluation of the Nageotte chamber and the Abbott Cell Dyn 3500 analyser Preparing the patient for bone marrow transplantation: nursing care issues Prevention of transfusion‐transmitted cytomegalovirus infection Comparison of platelet loss during leukocyte reduction at 4, 24, and 48 hours postcollection using a Closed System Apheresis Kit with Integral filter Leukocyte depletion of blood products and post-transfusion infections Viral inactivation and reduction in cellular blood products Anaphylactoid transfusion reactions associated with a positively charged white-cell reduction filter: a case report. leukocyte-reduced blood components in transfusion medicine: Current Indications and Prospects for the Future Indications of phenotyped, leukocyte-depleted, CMV negative or irradiated homologous erythrocyte concentrates in adult surgery Transfusion and the use of blood products Special Issues in Transfusion Medicine Comparison of Flow Cytometric Methods for the Enumeration of Residual Leucocytes in Leucoreduced Blood Products: A Multicenter Study.
is cites work of	wds:Q36921712-AD65921A-E19B-4F48-9E78-AC91521B42B6 wds:Q37869625-678ED2FE-A8D6-4D49-9C60-00CE512B4A1E wds:Q40945066-B3201AD4-5FB0-400D-8B07-33960315522B wds:Q73192487-9D494BBA-3DE2-4F32-BC87-20353119644E wds:Q70138186-F0203C3E-FB00-43FC-A6A7-5A4330C14629

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software